Vertex Pharmaceuticals Incorporated

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Rok finansowy 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 62 78 167 161 69 103 161 216 199 176 102 143 1,411 1,527 1,212 580 1,032 1,702 2,489 3,048 4,163 6,206 7,574 8,931 9,839 11,020
Przychód Δ r/r 0.0% 26.8% 114.4% -3.8% -57.1% 48.6% 56.6% 34.5% -8.0% -11.8% -41.9% 40.5% 883.9% 8.3% -20.6% -52.1% 77.9% 64.9% 46.2% 22.5% 36.6% 49.1% 22.1% 17.9% 10.2% 12.0%
Marża brutto 105.5% 94.8% 76.3% 82.4% 95.5% 94.5% 93.7% 94.4% 93.0% 91.1% 86.1% 91.1% 94.3% 81.7% 89.3% 89.5% 87.8% 87.6% 88.9% 86.6% 86.8% 88.1% 88.1% 87.9% 87.2% 86.1%
EBIT (mln) -40 -39 -92 -120 -265 -155 -150 -229 -420 -463 -613 -696 114 2 -903 -692 -469 10 123 635 1,198 2,856 2,782 4,307 3,750 -233
EBIT Δ r/r 0.0% -2.3% 137.3% 30.3% 121.2% -41.5% -3.2% 52.8% 83.3% 10.2% 32.6% 13.5% -116.4% -98.0% -38841.3% -23.4% -32.3% -102.1% 1140.4% 415.4% 88.5% 138.5% -2.6% 54.8% -12.9% -106.2%
EBIT (%) -64.3% -49.5% -54.8% -74.2% -382.6% -150.7% -93.2% -105.9% -210.9% -263.6% -601.1% -485.5% 8.1% 0.2% -74.5% -119.3% -45.4% 0.6% 5.0% 20.8% 28.8% 46.0% 36.7% 48.2% 38.1% -2.1%
Koszty finansowe (mln) 0 0 0 0 0 0 0 -8 0 13 13 19 37 15 23 73 84 81 58 34 59 58 62 55 44 31
EBITDA (mln) -33 -15 -24 -94 -66 -104 -91 -202 -378 -457 -543 -662 222 4 505 -611 -473 15 311 663 1,458 3,188 2,789 4,345 3,932 486
EBITDA(%) -52.9% -18.8% -14.4% -58.4% -96.1% -101.1% -56.5% -93.3% -190.0% -260.3% -531.8% -461.9% 15.7% 0.3% 41.6% -105.3% -45.8% 0.9% 12.5% 21.8% 35.0% 51.4% 36.8% 48.7% 40.0% 4.4%
Podatek (mln) 1 1 -2 -11 24 29 62 -18 -21 -31 19 19 19 39 -289 7 30 17 -107 -1,487 218 405 388 910 760 784
Zysk Netto (mln) -41 -40 -66 -109 -197 -166 -203 -207 -391 -460 -642 -755 30 -107 -445 -739 -558 -112 263 2,097 1,177 2,712 2,342 3,322 3,620 -536
Zysk netto Δ r/r 0.0% -3.3% 67.0% 64.0% 81.2% -15.5% 22.4% 1.7% 89.1% 17.5% 39.5% 17.6% -103.9% -461.9% 315.8% 66.0% -24.4% -79.9% -335.1% 695.8% -43.9% 130.4% -13.6% 41.8% 9.0% -114.8%
Zysk netto (%) -66.6% -50.8% -39.5% -67.4% -284.6% -161.8% -126.4% -95.6% -196.6% -262.0% -628.7% -526.3% 2.1% -7.0% -36.7% -127.2% -54.1% -6.6% 10.6% 68.8% 28.3% 43.7% 30.9% 37.2% 36.8% -4.9%
EPS -0.8 -0.59 -0.89 -1.43 -2.56 -2.12 -2.28 -1.83 -3.03 -3.27 -3.7 -3.77 0.14 -0.5 -1.98 -3.14 -2.31 -0.46 1.06 8.25 4.58 10.44 9.09 12.97 14.05 -2.08
EPS (rozwodnione) -0.8 -0.59 -0.89 -1.43 -2.56 -2.12 -2.28 -1.83 -3.03 -3.27 -3.7 -3.77 0.14 -0.5 -1.98 -3.14 -2.31 -0.46 1.04 8.09 4.51 10.29 9.01 12.82 13.89 -2.08
Ilośc akcji (mln) 51 68 74 76 77 79 89 113 129 141 173 200 205 212 225 235 241 244 249 254 257 260 258 256 258 258
Ważona ilośc akcji (mln) 51 68 74 76 77 79 89 113 129 141 173 200 209 212 225 235 241 245 253 259 261 263 260 259 260 258
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD